Moncef Slaoui, who headed the Operation Warp Speed vaccine-development effort under the Trump administration, is returning to his previous role as a venture capitalist and announced Tuesday the launch of a new company, Centessa Pharmaceuticals.
Centessa, which will merge 10 small biotechnology companies into a larger entity, was founded by the venture firm Medici Partners, which Slaoui joined in September 2017; it has raised $250 million from more than a dozen investment funds. Slaoui will serve as executive chairman. Saurabh Saha, most recently the global head of translational medicine at Bristol-Myers Squibb, will be CEO.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
GET STARTEDWhat is it?
STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
What's included?
- Daily reporting and analysis
- The most comprehensive industry coverage from a powerhouse team of reporters
- Subscriber-only newsletters
- Daily newsletters to brief you on the most important industry news of the day
- STAT+ Conversations
- Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
- Exclusive industry events
- Premium access to subscriber-only networking events around the country
- The best reporters in the industry
- The most trusted and well-connected newsroom in the health care industry
- And much more
- Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
"company" - Google News
February 16, 2021 at 06:35PM
https://ift.tt/3djJCrh
Moncef Slaoui to test his R&D philosophy in a new company - STAT
"company" - Google News
https://ift.tt/33ZInFA
https://ift.tt/3fk35XJ
Bagikan Berita Ini
0 Response to "Moncef Slaoui to test his R&D philosophy in a new company - STAT"
Post a Comment